These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26193303)

  • 21. Virion-targeted viral inactivation: new therapy against viral infection.
    Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
    Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors.
    Boutimah F; Eekels JJ; Liu YP; Berkhout B
    Antiviral Res; 2013 Apr; 98(1):121-9. PubMed ID: 23439083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
    Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
    J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection and AIDS: new biology, therapeutic advances, and clinical implications. Introduction.
    Miles SA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S1-2. PubMed ID: 9389309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a durable treatment of HIV-1 infection using RNA interference.
    Eekels JJ; Berkhout B
    Prog Mol Biol Transl Sci; 2011; 102():141-63. PubMed ID: 21846571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes.
    Mautino MR; Morgan RA
    AIDS Patient Care STDS; 2002 Jan; 16(1):11-26. PubMed ID: 11839215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS.
    Chung J; DiGiusto DL; Rossi JJ
    Expert Opin Biol Ther; 2013 Mar; 13(3):437-45. PubMed ID: 23394377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell directed gene therapy.
    Engel BC; Kohn DB
    Front Biosci; 1999 May; 4():e26-33. PubMed ID: 10228093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
    Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
    Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
    Marasco WA; LaVecchio J; Winkler A
    J Immunol Methods; 1999 Dec; 231(1-2):223-38. PubMed ID: 10648940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small RNAs to treat human immunodeficiency virus type 1 infection by gene therapy.
    Goguen RP; Malard CM; Scarborough RJ; Gatignol A
    Curr Opin Virol; 2019 Oct; 38():10-20. PubMed ID: 31112858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies.
    Lamothe B; Joshi S
    Front Biosci; 2000 May; 5():D527-55. PubMed ID: 10799355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.
    Garg H; Joshi A
    Hum Gene Ther; 2016 May; 27(5):400-15. PubMed ID: 26800572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted delivery methods for RNA interference are necessary to obtain a potential functional cure for HIV/AIDS.
    Cisneros E; Sherwani N; Lanier OL; Peppas NA
    Adv Drug Deliv Rev; 2023 Aug; 199():114970. PubMed ID: 37385543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.
    Saifullah M; Laghzaoui O; Ozyahyalar H; Irfan A
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2430-2463. PubMed ID: 38567606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could bone marrow transplantation cure AIDS?: review.
    Huzicka I
    Med Hypotheses; 1999 Mar; 52(3):247-57. PubMed ID: 10362285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.